secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001477932-25-001958
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioNexus Gene Lab shareholders approve reverse stock split at 1:5 to 1:10 ratio
-------------------------------------------------------------------------------

- 98.36% of votes cast (4.94B) approved reverse stock split; ratio range of 1:5 to 1:10 at Board discretion.
- Series Z Preferred Stock with 5B votes mirrored common stock votes exclusively for this proposal.
- Adjournment proposal also passed with 98.60% approval.
- Special Meeting held March 19, 2025; no other matters voted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793225001958/0001477932-25-001958-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793225001958/bglc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-001958

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer